Gadoxetic acid-enhanced magnetic resonance imaging (MRI) has been widely used in detection and diagnosis for hepatocellular carcinoma (HCC), while transient severe motion artifact that affects the arterial phase (AP) images quality and reduces diagnosis performance remains a concern. A new diagnosis criterion for HCC integrating CTAP and MRAP images was introduced in this study and achieved a high sensitivity and comparable specificity when compared with the gadoxetic acid-enhanced MRI only. It may be able to improve the diagnostic performance of gadoxetic acid-enhanced MRI in patients with HCCs and further affect the clinical treatment plan.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords